MedTech Innovator Asia Pacific 2022 Accelerator Program

Stay tuned for more updates on our exciting Online Pitch Events!

The Selection Results are Out, Thank You All 2022 Applicants!

We have selected 20 brilliant Startups that will be joining our Cohort for the 2022 MedTech Innovator Asia Pacific Accelerator Program. For those of you who are not selected this year, we encourage you to apply for the 2023 Program that will be opened in November 2022. For the time being, do join our open curriculum MedTech Innovator Asia Pacific Live which will be streamed live on the MedTech Innovator Youtube channel every Wednesday. The webinar will talk about the various aspects of the MedTech world and will feature highly-experienced experts in the field. Follow our social media to stay updated with all things MedTech Innovator APAC. All the best everyone and keep on innovating!

About MedTech Innovator Asia Pacific

MedTech Innovator is the medical technology industry’s global showcase and accelerator for innovative medical device, digital health and diagnostic companies. Our mission is to improve the lives of patients by accelerating the growth of companies that are transforming the healthcare system. MedTech Innovator is the largest platform of its kind, providing participants with broad exposure to the leading players in the medtech industry. To accelerate innovation in Asia, we have partnered with the Asia Pacific Medical Technology Association (APACMed 亚太医疗技术协会). APACMed is the first and only regional association to provide a unified voice for the medical technology industry in Asia.

MedTech Innovator's US program

For Startups interested in the US or European markets, MedTech Innovator also offers a parallel competition and program providing content and benefits regarding accessing and operating in the US and EU regions. Companies may apply to both the Asia Pacific and US-based programs. Please visit our MedTech Innovator US page for more information.

MedTech Innovator Asia Pacific 2022 Cohort

In 2022, MedTech Innovator Asia Pacific will recognize the 20 best-in-class startups across the Asia Pacific regions. Startups selected for this honor receive a slot in the MedTech Innovator Asia Pacific Cohort. The MedTech Innovator Cohort is an annual program that provides startups with high profile visibility to healthcare investors, stakeholders, and decision makers, access to a network of mentors and peers, and participation in a customized virtual curriculum.

MedTech Innovator Cohort startups will receive mentorship and coaching through one-on-one matching with one or more mentors from our corporate partners to help with commercialization throughout Asia Pacific. They will also have access to the webinar sessions from our parallel US program providing information regarding accessing and operating in the US and EU regions. Additionally, the MedTech Innovator Asia Pacific Cohort startups are eligible to compete for up to US $300,000 in cash and awards. All medical device, diagnostic, or digital health startups are eligible to apply.

MedTech Innovator 2021 Grand Finals

Asia Pacific Program Benefits

MedTech Innovator Pitch – The highest scoring companies from the online application review are invited to participate in regional pitch events, awarding the opportunity to present to a variety of industry-leading judges and key opinion leaders. In-person pitch event judges include members of the MedTech Innovator leadership team, investors, providers, and senior executives from world-class multinationals and medtech companies. Historically, participation has resulted in financial investment, recruitment of board advisors, and establishment of research partnerships for startups. All companies invited to pitch will be provided with review feedback summaries based on their online application and in-person pitch.

MedTech Innovator Cohort – 20 companies will be selected to participate in the MedTech Innovator Cohort. These companies will receive one complimentary registration to APACMed’s Asia Pacific MedTech Forum in September 2022. At this gathering of industry leaders from across the Asia Pacific, companies will participate in the MedTech Innovator Showcase, an on-stage interactive program. The showcase highlights the most innovative companies in sector-based sessions, moderated by leading corporate executives and investors. Opportunities will also include networking and pitching to investors, manufacturers, providers. All 20 companies of the cohort will receive customized mentorship and the eligibility to compete for the Grand Prize.

Eligibility & Requirements

All early- to mid-stage medical device, diagnostic, or digital health companies are encouraged to apply.

Companies that are accepted to the program must commit a co-founder or senior member of their leadership team to attend APACMed’s Asia Pacific MedTech Forum in September 2022. All companies selected for the showcase will prepare a 1-minute pitch video to be played during their showcase session at the Asia Pacific MedTech Forum.

MedTech Innovator is a nonprofit and does not require equity from participating companies.

Apply Now

1. Register an account

If you haven’t already done so, you’ll need to set up an account. Click the Register button below to go to the registration page. Enter a username and email and click the Register button. That will send you an email with a link where you can set your password. Then, proceed to the next steps below.

Login Register

2. Complete your application 

Submit a new application on your MedTech Innovator Member Page. You’ll be able to save your application in-progress and come back later to make changes and additions as needed.

3. Be ready to pitch!

2022 Key Dates

Date Event
Late January 2022 APAC Program Application Deadline
Mar – May 2022 Online Pitch Events for Selected Companies
OPE 1: 30 March 2022
OPE 2: 13 April 2022
OPE 3: 17 May 2022
OPE 4: 1 June 2022
OPE 5: 21 June 2022
June 2022 Selection for 2022 Cohort
June – Sep 2022 APAC 2022 Mentoring & Virtual Accelerator Program
Sept 26-27 2022 MTI APAC 2022 Showcase & Finals Competition at APACMed Forum

Program Sponsors: